Skip to main content
. 2023 Oct 31;12(4):245–256. doi: 10.7762/cnr.2023.12.4.245

Table 2. Baseline characteristics of the participants.

Variable Placebo (n =37) Collagen (n = 37) p value*
Age (yr) 60.5 ± 6.1 62.2 ± 6.5 0.243
50–64 30 (81) 27 (73) 1.000
≥ 65 7 (19) 10 (27)
Sex (M/F) 8 (22)/29 (78) 8 (22)/29 (78) 0.407
Body weight (kg) 65.1 ± 8.1 64.3 ± 8.1 0.647
BMI (kg/m2) 25.7 ± 2.3 25.9 ± 2.0 0.767
WHR 0.91 ± 0.05 0.92 ± 0.04 0.313
Education level 0.263
≤ Middle school 3 (8) 8 (22)
High school 22 (59) 19 (51)
≥ University 12 (32) 10 (27)
Marital status 0.314
Married 37 (100) 36 (97)
Single 0 (0) 1 (3)
Smoker 3 (8) 3 (8) 0.898
Energy intake (kcal/day) 1,568.7 ± 398.0 1,655.5 ± 399.0 0.352
IPAQ (METs) 2,828.9 ± 2,001.7 3,086.6 ± 2,809.1 0.651
Menopausal women 27 (93) 28 (97) 0.839

Data are presented as means ± standard deviations or number (%).

The participants take the collagen peptide supplement (15 g/day) or placebo once daily during the 12-week intervention period.

No statistically significant differences in age, sex, body weight, BMI, WHR, educational level, marital status, smoking status, energy intake, physical activity, and menopausal status were determined the between placebo and collagen groups at study baseline.

F, female; M, male; BMI, body mass index; WHR, waist–hip ratio; IPAQ, international physical activity questionnaire; MET, metabolic equivalent task; n, number of subjects.

*p value obtained by the χ2 test or Student’s t-test; The score is calculated using the IPAQ, with a higher score indicating greater physical activity.